Last week's top financial articles reveal investor focus on inflation concerns and growth sectors like biotech and nuclear energy. The ALPS Medical Breakthroughs ETF (SBIO) led with a 12% gain driven by FDA approvals and M&A activity. Interest in derivatives strategies was highlighted at a Nasdaq event, showing diverse investor approaches. Persistent inflation keeps high-income ETFs popular, while engineering firms are seen as key to nuclear energy expansion. The T. Rowe Price Equity Income ETF gained recognition as a top active value ETF for 2026, signaling strong fund performance and investor confidence.
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
The global hybrid robots market is projected to grow from $5.68 billion in 2026 to $10.03 billion by 2030, with a CAGR of 15.3%. Growth is fueled by advances in AI, autonomous operations, and smart manufacturing, alongside rising demand for robots in...
The global warehouse shuttle software market is projected to grow from $1.57 billion in 2026 to $2.66 billion by 2030, with a CAGR of 14.1%. Growth is fueled by rising e-commerce, warehouse automation, AI-driven orchestration, and robotic material ha...
